Kenneth Gordon, MD
Dermatology · Wauwatosa, WINPI 1790865806
Payments from drug & device makers
Across 732 payments — averaging $1212.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$215K
- Eli Lilly$114K
- E.r. Squibb & Sons, L.L.C.$89K
- Johnson & Johnson$67K
- Lilly USA, LLC$63K
- Amgen$50K
- plus $289K from 17 others
Across 19 payments — averaging $1157.37 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- UCB, Inc.$19K
- Eli Lilly$2K
- Bristol Myers Squibb$952
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 174 | $214,984 |
| Eli Lilly | 17 | $114,360 |
| E.r. Squibb & Sons, L.L.C. | 78 | $89,259 |
| Johnson & Johnson | 61 | $67,315 |
| Lilly USA, LLC | 8 | $63,056 |
| Amgen | 57 | $49,681 |
| UCB SA | 44 | $46,923 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $38,255 |
| LEO Pharma AS | 42 | $32,458 |
| Janssen Research & Development, LLC | 2 | $32,089 |
| UCB, Inc. | 15 | $30,192 |
| Novartis | 37 | $24,700 |
| Janssen Global Services, LLC | 47 | $22,186 |
| Boehringer Ingelheim International GmbH | 71 | $14,113 |
| Pfizer | 7 | $11,964 |
| Bristol Myers Squibb | 21 | $10,757 |
| Incyte Corporation | 30 | $9,423 |
| Sanofi-aventis U.S. LLC | 3 | $7,517 |
| LEO Pharma Inc. | 2 | $4,993 |
| Boehringer Ingelheim | 2 | $2,799 |
| Novartis Pharma AG | 1 | $356 |
| Sun Pharmaceutical Industries Inc. | 2 | $48 |
| Arcutis Biotherapeutics, Inc. | 1 | $28 |
How this compares
$887,457 in reported general payments places this provider in the 95th percentile of 260 dermatology providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other dermatology in Wauwatosa
- Gretchen RothWauwatosa$147K
- Keri ChaneyWauwatosa$26K
- Lisa ArkinMadison$1.4M
- David NelsenJanesville$1.1M
- Gabriela MaloneyOconomowoc$725K
- Ashley DietrichMilwaukee$466K
- Martin OkunFort Atkinson$247K
- Betsy WernliManitowoc$177K
- Clarence Brownla Crosse$152K
- Daniel OpelSheboygan$118K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.